|
|
| Dr. Germano DiSciascio discusses the results of the ARMYDA-5 trial at ACC 2007 |
Dr. Germano DiSciascio discusses the results of the ARMYDA-5 trial at TCT 2007. Among
patients undergoing PCI, a 600 mg loading dose of clopidogrel at least 6 hours before the
case was associated with improved platelet aggregometry when compared to the
administration of 600 mg of clopidogrel at the time of PCI. Despite these improvements in
platelet aggregometry, there was no improvement in clinical outcomes. Keywords: plavix.
Sponsorship for interviews this year at TCT 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from Daiichi Sankyo Lilly,
Genentech, Pfizer, Sanofi-Aventis, Schering-Plough and Scios.
[ Download video ] |
|
No comments have been submitted
|